🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ming-Hua Zheng

Wenzhou Medical University

ORCID: 0000-0003-4984-2631

Also affiliated with First Affiliated Hospital of Wenzhou Medical University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study”.

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

Journal of Hepatology(2020)10.1016/j.jhep.2020.09.024
N/A
0.940DataRank · unranked
527 citations

Andrew M. Moon, Jonathan Cook, Sherief Abd-Elsalam, Costica Aloman, Matthew J. Armstrong +25 more

Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure

Expert Review of Gastroenterology & Hepatology(2018)10.1080/17474124.2018.1424540
N/A
0.717DataRank · unranked
8 citations

Yao-Yao Xie, Pei-Wu Zhu, Xiao-Dong Wang, Zhuo Lin, Yan Wang +8 more

Activating Adenosine Monophosphate–Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice

Hepatology(2020)10.1002/hep.31568
N/A
0.668DataRank · unranked
85 citations

Zhifeng Huang, Genxiang Cai, Xia Fan, Xiaoqing Yan, Zhengshuai Liu +15 more

Bariatric surgery for metabolic dysfunction-associated steatotic liver disease (MASLD): Current knowledge of mechanisms

Hepatology(2025)10.1097/hep.0000000000001417
N/A
0.464DataRank · unranked
21 citations

Sander Lefere, Adrien Guillot, Ming-Hua Zheng, Frank Tacke, Hanyang Liu

Metabolic dysfunction and alcohol-associated liver disease (MetALD)

eGastroenterology(2025)10.1136/egastro-2025-100319
N/A
0.442DataRank · unranked
18 citations

Juan Pablo Arab, S. Liangpunsakul, Wen-Xing Ding, Gyöngyi Szabó, Wajahat Z. Mehal +16 more

Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study

Journal of Hepatology(2021)10.1016/j.jhep.2021.04.026
N/A
0DataRank · unranked
101 citations

Zhiyun Hou, Jianxin Liu, Ye Gu, Yunhong Wu, Zhenhuai Chen +40 more

Gut bacteria alleviate smoking-related NASH by degrading gut nicotine

Nature(2022)10.1038/s41586-022-05299-4
N/A
0DataRank · unranked
216 citations

Lulu Sun, Guangyi Zeng, Zhe Shen, Kai Wang, Limin Yin +19 more

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention

Cardiovascular Diabetology(2022)10.1186/s12933-022-01697-0
N/A
0DataRank · unranked
162 citations

Jingjing Cai, Giovanni Targher, Christopher D. Byrne, Michael D Shapiro, Ki‐Chul Sung +7 more

Consensus Statement on the definition and classification of metabolic hyperferritinaemia

Nature Reviews Endocrinology(2023)10.1038/s41574-023-00807-6
N/A
0DataRank · unranked
103 citations

Elena Corradini, Leon A. Adams, Elmar Aigner, Saleh A. Alqahtani, Marco Arrese +25 more

Myeloid‐Cell–Specific IL‐6 Signaling Promotes MicroRNA‐223‐Enriched Exosome Production to Attenuate NAFLD‐Associated Fibrosis

Hepatology(2020)10.1002/hep.31658
N/A
0DataRank · unranked
218 citations

Shi Yin, Ruixue Ren, Siqi Liu, Yong Liang, Yuxiao Liu +6 more